Patent ID: 11964963
Assignee: ASKAT INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C  Y | IPC C

Claim 0:
1. A crystalline form of an HCl salt of 2-[3-({1-[2-(dimethylamino)ethyl]-2-(2,2-dimethylpropyl)-1H-1,3-benzodiazol-5-yl}sulfonyl)azetidin-1-yl]ethan-1-o1, wherein the crystalline form is characterized by a powder X-ray diffraction (XRPD) pattern comprising peaks in terms of 2-Theta, at 5.9, 6.6, 8.9, 11.8, 13.2, 14.5, 15.6, 16.0, 17.4, 18.3, 19.5, 20.2, 22.0, 26.6, and 27.0 degrees 2-Theta+/−0.2 degrees 2-Theta for each value.